Skip to main content

Search

By Jeff Lagasse | 10:09 am | November 11, 2025
The AG wants a restraining order against marketing Tylenol as safe during pregnancy and stop a dividend payout.
By Jeff Lagasse | 08:30 pm | November 02, 2025
The initiative has generated $4.7 million in member savings since its inception.
By Jeff Lagasse | 12:15 am | October 15, 2025
The bill requires PBMs to be licensed and end the practice of spread pricing, among other requirements.
By Jeff Lagasse | 10:53 am | October 13, 2025
The drugmaker will sell medications to Medicaid at most favored nation prices, the administration says.
By Jeff Lagasse | 10:39 am | September 17, 2025
The new model is intended to provide pharmacies with better financial means to stock more medicines, which is expected to alleviate drug shortages.
By Jeff Lagasse | 10:50 am | September 15, 2025
Reliance on the “big three” PBMs – CVS Caremark, Express Scripts and Optum Rx – has been slipping over the past year.
By Jeff Lagasse | 03:05 pm | September 11, 2025
The group says an “unchecked” model would undermine the goal of allowing safety net providers to stretch federal resources.
By Jeff Lagasse | 10:44 am | September 08, 2025
Amneal Pharmaceuticals’ laboratory procedures resulted in visibly contaminated injectable medications, FDA says.
By Jeff Lagasse | 10:14 am | September 02, 2025
PBMs’ overseas group purchasing organizations may be used to avoid transparency and oversight, committee says.
By Jeff Lagasse | 09:49 am | August 28, 2025
The merger is intended to lower the cost of specialty medications and high-cost drug classes like GLP-1s.